Copyright
©The Author(s) 2021.
World J Hepatol. Jan 27, 2022; 14(1): 274-286
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.274
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.274
Questions | Patients’ answer “YES” number (%) | Patients’ answer “NO” number (%) |
1 Are you aware that the novel coronavirus is transmitted to people? | 76 (93.8) | 5 (6.2) |
2 Are you aware that symptoms including fever, cough, and breathing difficulties are signs of alarm? | 76 (93.8) | 5 (6.2) |
3 Are you aware that people with chronic liver disease are at higher risk of developing a severe form of the disease? | 69 (85) | 12 (15) |
4 Are you aware that when you go out, you always have to use personal protective equipment such as masks and gloves? | 77 (95) | 4 (5) |
5 Do you always respect prevention and protection measures such as social distancing? | 60 (74) | 21 (26) |
6 Do you use adequate hygiene measures such as frequently washing your hands? | 60 (74) | 21 (26) |
7 During this period, did you need to contact your general physician for your liver disease? | 12 (15%) | 69 (85) |
8 If you answered yes, did you have difficulty in contacting him/her? | 11 (91.7)1 | 1 (8.3) |
9 During this period, did you need to contact a Gastroenterologist specialist for your liver disease? | 12 (15%) | 69 (85) |
10 If you answered yes, did you have difficulty in contacting him/her? | 8 (67%)2 | 4 (33.3) |
11 Have you received more detailed information about the management of your therapy? | 5 (15.6) | 27 (84.4) |
12 Do you know that immunosuppressed patients are more at risk of getting severe acute respiratory syndrome coronavirus 2-infection? | 29 (90.6%) | 3 (9.4%) |
13 Have you thought about modifying your immunosuppressive therapy on your own? | 9 (28.2%) | 23 (71.8%) |
14 Did you manage to perform the six-month follow-up ultrasound for hepatocellular carcinoma surveillance? | 29 (60%)3 | 20 (40%) |
- Citation: Zannella A, Fanella S, Marignani M, Begini P. COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study. World J Hepatol 2022; 14(1): 274-286
- URL: https://www.wjgnet.com/1948-5182/full/v14/i1/274.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i1.274